Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
13th Annual Meeting of the International Herpes Management Forum
New Insights into Episodic Short-course Therapy of Herpes Infection
Prague, Czech Republic / October 27-29, 2006
Prague - Infection with herpes simplex virus (HSV) remains a major health issue throughout the world. The epidemiology of infection continues to evolve, as childhood acquisition of HSV-1 has decreased dramatically in the last half-century,...
Congrès Synergie et Résistances
Strategies for Drug Selection: Growing Insight into Resistance Mutations
Aix-en-Provence, France / October 26-27, 2006
The goal of antiretroviral therapy (ART) in all patients, whether they are receiving the first or fifth regimen, is to reduce the viral load (VL) <50 HIV RNA copies/mL. This level of suppression is associated with a low risk of...
Based on the following published articles: Current Medical Research and Opinion 2006;22(7):1307-10 and 2006;22(9):1699-702
Short-course Treatment for Recurrent Herpes Infections
Infection by herpes simplex virus (HSV) often results in a lifelong pattern of intermittent symptomatic recurrence, which arises from reactivation of latent virus. Recurrent genital herpes can have a devastating emotional, psychological and...
44th Annual Meeting of the Infectious Diseases Society of America
Vaccine Protection Against Human Papillomavirus: Extending the Experience
Toronto, Ontario / October 12-15, 2006
Toronto - While many sexually transmitted infections are declining worldwide, the exception is sexually transmitted viral infections. Now that there is a vaccine against human papillomavirus (HPV), there is hope for greater control of HPV...
44th Annual Meeting of the Infectious Diseases Society of America
Antifungal Prophylactic Strategies for Patients at High Risk
Toronto, Ontario / October 12-15, 2006
Toronto - According to investigators, antifungal prophylaxis may be considered in select patient populations at high risk of developing an invasive fungal infection. In the neutropenic population, fluconazole prophylaxis is the most widely...
44th Annual Meeting of the Infectious Diseases Society of America
New Developments With Carbapenem: Update on Pseudomonas Susceptibility
Toronto, Ontario / October 12-15, 2006
Toronto - Concerns have been raised that the use of the carbapenem ertapenem might select out strains of Pseudomonas aeruginosa that are resistant to imipenem, thus forfeiting an effective class of agents used to treat resistant P....
44th Annual Meeting of the Infectious Diseases Society of America
Increasing Awareness of Vaccine-preventable Diseases
Toronto, Ontario / October 12-15, 2006
Toronto - The successful eradication of vaccine-preventable diseases (VPDs) in children has not been duplicated in adults and each year in the US, over 70,000 adults die of VPDs. Increasing rates of vaccination among adults starts with...
44th Annual Meeting of the Infectious Diseases Society of America
Optimizing Results with NRTI Regimens: Tailored Approach Key to Success
Toronto, Ontario / October 12-15, 2006
Guidelines from both the panel of the International AIDS Society-USA (IAS-USA) and the US Department of Health and Human Services (DHHS) 2006 suggest antiretroviral therapy (ART) is warranted when CD4+ T-cell counts drop below 200 cells/mm3...
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Retaining Antibiotic Potency Against Multidrug-resistant Infections
San Francisco, California / September 27-30, 2006
San Francisco - With the growing array of mechanisms of antimicrobial resistance, it has become increasingly difficult to create effective broad-spectrum antibiotics for empiric therapy. Recent research has focused on agents specifically...